Skip to content

Unraveling OCD: Using Brain Stimulation to Investigate Control

The anterior cingulate double cone transcranial magnetic stimulation (ACDC TMS) as an instrument for the investigation of inhibitory control in patients with obsessive compulsive disorder (OCD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74711040
Enrollment
30
Registered
2024-05-03
Start date
2022-12-01
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inhibitory control in patients with obsessive compulsive disorder Mental and Behavioural Disorders

Interventions

The participant was randomly (by computer program) allocated to one of the two groups: a) active 20Hz ACDC TMS, 100% of motor threshold, 40 trains, 50 pulses per train, 18 minutes duration
1 session
b) sham ACDC TMS with a sham coil applied either to mPFC
1 session. Right after the stimulation: EEG with Stroop task and side effect assessment took place.

Sponsors

Charles University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female inpatients or outpatients from the daycare center entering six-week CBT at age 18-70 years 2. Meet DSM-V criteria for OCD as determined by Structured Clinical Interview for DSM-5 (SCID-5) 3. The mental ability to understand and sign Informed Consent Form 4. Being on a stable and adequate dose of antidepressants and/or antipsychotics (monotherapy or combination) for atleast one week prior to enrolment and if clinically appropriate to continue on an unchanged dose of medication during the trial

Exclusion criteria

Exclusion criteria: 1. Psychiatric comorbidity on axis I and II according to DSM V in six months before enrollment to the study 2. Personality disorder that makes participation in the trial difficult 3. History of substance dependence in the last year except nicotine 4. Contraindications of rTMS (history of epilepsy or any neurologic condition likely to increase risk of seizure, mass brain lesions, cerebrovascular accident, metal in the head, a history of major head trauma with unconsciousness longer than 5 minutes) 5. Pregnancy or breast-feeding 6. Patients with severe somatic disorders (cardiovascular disease, neoplasms, endocrinology disorders etc.) 7. Patients treated with electroconvulsive therapy less than 3 months before enrollment or suffering from neurologic disorder (e.g., epilepsy, head trauma with loss of consciousness) and patients using any treatment which can strongly affect EEG 8. Substantial suicidal risk as judged by the treating psychiatrist 9. Sensory and motor impairment precluding the participation in computer tests

Design outcomes

Primary

MeasureTime frame
Inhibitory control measured via the interference effect in the Stroop task, measured as the reaction time to incongruent minus the reaction time to congruent stimuli right after the active and sham ACDC TMS stimulation

Secondary

MeasureTime frame
Measured right after the active and sham ACDC TMS stimulation: 1. Inhibitory control measured via the reaction times change and error count in the Stroop task (as less sensitive markers) 2. Electrophysiological effect of the active and sham ACDC TMS stimulation measured using EEG

Countries

Czech Republic

Contacts

Public ContactOlga Laskov
olga.laskov@nudz.cz+420 283 088 148

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026